A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS
Main Authors: | P. Sandercock, E. Berge, M. Dennis, J. Forbes, P. Hand, J. Kwan, S. Lewis, R. Lindley, A. Neilson, B. Thomas, J. Wardlaw |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2002-01-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta6260 |
Similar Items
-
Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
by: Renee Y Hsia, et al. -
The early outcome of thrombolytic treatment in ischaemic stroke patients: a retrospective analysis
by: Dariusz Kotlęga, et al.
Published: (2019-03-01) -
Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy
by: de Weerd Leonie, et al.
Published: (2012-07-01) -
Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
by: Ming Liu, et al. -
Mechanisms underlying the endogenous neuroprotection of hamartin in ischaemic stroke
by: Hadley, Gina Louise
Published: (2016)